Otrivine Anti-Allergie (Fluticasone Propionate)

Fluticasone propionate, the active ingredient in Otrivine Anti-Allergie, is a corticosteroid (glucocorticoid) presented as a nasal spray for topical nasal use. It treats allergic rhinitis and seasonal allergic nasal symptoms in patients requiring anti‑allergic therapy.

GNH USA supplies Otrivine Anti-Allergie as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivine Anti-Allergie is a nasal corticosteroid indicated for conditions affecting the nasal mucosa and allergic response. - Allergic rhinitis: reduces nasal congestion, itching and sneezing associated with seasonal or perennial allergens. - Seasonal allergic nasal symptoms: alleviates inflammation and discharge during pollen or mold exposure. - Perennial allergic rhinitis: provides sustained relief of chronic nasal inflammation caused by indoor allergens such as dust mites.

Adverse reactions are generally mild to moderate and reflect local or systemic exposure to a corticosteroid.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Throat irritation or dryness. - Cough. - Unpleasant taste.

Serious or Rare Side Effects: - Nasal septal perforation. - Secondary fungal infection of the nasal passages. - Elevated intra‑ocular pressure or glaucoma. - Systemic corticosteroid effects such as adrenal suppression (rare with recommended use). - Severe allergic reaction (anaphylaxis).

When using Otrivine Anti-Allergie, consider the following safety measures: - Assess patient history: verify no recent nasal surgery or trauma. - Monitor for infection: discontinue if signs of nasal or sinus infection appear. - Caution in glaucoma: avoid prolonged use in patients with elevated intra‑ocular pressure. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Pediatric use: follow age‑specific guidelines and avoid excessive dosing. - Store at ambient temperature: keep below 25°C, protect from moisture and keep in original packaging.

Fluticasone propionate nasal spray has a low potential for systemic drug interactions, but certain agents may modify its safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic exposure.

Moderate Interactions (Monitor Closely): - Nasal decongestant sprays: concurrent use can increase risk of nasal mucosal irritation. - Antifungal nasal preparations: may alter local flora and increase infection risk. - Systemic corticosteroids: additive systemic glucocorticoid effects. - Antihistamines: may enhance sedative effects when combined with sedating antihistamines. - Immunosuppressants: monitor for heightened risk of local infection.